SAN DIEGO, July 11, 2013 (GLOBE NEWSWIRE) -- SpectraScience, Inc. (OTCQB:SCIE) today announced the Company will hold a conference call at 9:00 a.m. Eastern (6:00 a.m. Pacific) on July 17th to provide an update on its business. Management will discuss the current status of the Company and recent positive developments and how they are expected to impact future deployment of the Company's products and technologies.
To access the call, please dial (877) 303-7908 and provide the Conference ID: 17392287. The conference call will also be broadcast live via the Internet and can be accessed through the "Investor Relations" page of the Company's website, www.spectrascience.com.
At the conclusion of the call, a replay will be available until July 23, 2013. To access the replay of the call dial (855) 859-2056 and provide the same Conference ID. A webcast archive will be available at www.spectrascience.com shortly after the call as well.
About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With approval for sale under the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.
CONTACT: Mike Oliver, CEO SpectraScience, Inc. 619-252-7641 email@example.comSource:SpectraScience, Inc.